Remifentanil inferior to neuromuscular blockers for successful tracheal intubation in adults at risk of aspiration
Written By : Aditi
Medically Reviewed By : Dr. Kamal Kant Kohli
Published On 2023-02-22 00:45 GMT | Update On 2023-02-22 00:45 GMT
Advertisement
France: An original investigation published in JAMA has concluded that Remifentanil was statistically inferior to neuromuscular blockers in adults at risk of aspiration during rapid sequence intubation.
There remains uncertainty on whether a rapid-onset opioid is non-inferior to a rapid-onset neuromuscular blocker during rapid sequence intubation?
Grillot et al. and colleagues from Nantes Université and 2Université Lille, France, did a study with the main objective of determining, "Are rapid-onset opioids non-inferior to rapid-onset neuromuscular blockers for rapid sequence intubation?"
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.